| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.879 | 0.003 | 0.944 | 5 Hydroxytryptamine 1 agonist | 0.772 0.003 CID_154699877 0.944 0.002 CID_154699526 | CID_154699526 | |
| 0.763 | 0.004 | 0.827 | 5 Hydroxytryptamine agonist | 0.584 0.004 CID_154699877 0.827 0.003 CID_154699526 | CID_154699526 | |
| 0.708 | 0.004 | 0.708 | 5 Hydroxytryptamine antagonist | 0.355 0.014 CID_154699877 0.699 0.004 CID_154699526 | ||
| 0.667 | 0.004 | 0.673 | 5 Hydroxytryptamine 1 antagonist | 0.432 0.005 CID_154699877 0.673 0.004 CID_154699526 | CID_154699526 | |
| 0.663 | 0.002 | 0.792 | 5 Hydroxytryptamine 1B agonist | 0.52 0.003 CID_154699877 0.792 0.002 CID_154699526 | CID_154699526 | |
| 0.569 | 0.003 | 0.649 | 5 Hydroxytryptamine 1B antagonist | 0.174 0.01 CID_154699877 0.649 0.003 CID_154699526 | CID_154699526 | |
| 0.477 | 0.003 | 0.599 | 5 Hydroxytryptamine 1D antagonist | 0.1 0.022 CID_154699877 0.599 0.003 CID_154699526 | CID_154699526 | |
| 0.437 | 0.022 | 0.437 | HERG channel blocker | 0.313 0.046 CID_154699877 0.214 0.082 CID_154699526 | ||
| 0.421 | 0.019 | 0.421 | Anticonvulsant | 0.373 0.025 CID_154699877 0.352 0.029 CID_154699526 | ||
| 0.402 | 0.005 | 0.402 | Dopamine D4 antagonist | 0.114 0.023 CID_154699877 0.284 0.008 CID_154699526 | ||
| 0.398 | 0.022 | 0.398 | Sigma receptor agonist | 0.316 0.036 CID_154699526 | ||
| 0.384 | 0.011 | 0.384 | 5 Hydroxytryptamine 2 antagonist | 0.135 0.05 CID_154699877 0.248 0.022 CID_154699526 | ||
| 0.375 | 0.002 | 0.457 | 5 Hydroxytryptamine 1D agonist | 0.095 0.004 CID_154699877 0.457 0.001 CID_154699526 | CID_154699526 | |
| 0.374 | 0.007 | 0.473 | Histamine antagonist | 0.156 0.028 CID_154699877 0.473 0.005 CID_154699526 | CID_154699526 | |
| 0.37 | 0.007 | 0.475 | Antihistaminic | 0.167 0.028 CID_154699877 0.475 0.005 CID_154699526 | CID_154699526 | |
| 0.389 | 0.029 | 0.389 | Potassium channel (Voltage-sensitive) blocker | 0.282 0.055 CID_154699877 0.167 0.124 CID_154699526 | ||
| 0.338 | 0.009 | 0.338 | 5 Hydroxytryptamine 2A antagonist | 0.11 0.042 CID_154699877 0.206 0.019 CID_154699526 | ||
| 0.264 | 0.011 | 0.264 | 5 Hydroxytryptamine 2C antagonist | 0.077 0.064 CID_154699877 0.198 0.017 CID_154699526 | ||
| 0.24 | 0.012 | 0.24 | 5 Hydroxytryptamine 1A antagonist | 0.13 0.023 CID_154699877 0.233 0.012 CID_154699526 | ||
| 0.217 | 0.007 | 0.217 | Multidrug resistance-associated protein 1 inhibitor | 0.096 0.085 CID_154699877 0.106 0.068 CID_154699526 | ||
| 0.232 | 0.033 | 0.302 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.117 0.084 CID_154699877 0.302 0.017 CID_154699526 | CID_154699526 | |
| 0.214 | 0.017 | 0.214 | Dopamine antagonist | 0.068 0.056 CID_154699877 0.154 0.025 CID_154699526 | ||
| 0.251 | 0.066 | 0.433 | Potassium channel blocker | 0.433 0.018 CID_154699877 | CID_154699877 | |
| 0.21 | 0.025 | 0.21 | 5 Hydroxytryptamine 2B antagonist | 0.161 0.036 CID_154699526 | ||
| 0.193 | 0.013 | 0.193 | 5 Hydroxytryptamine 7 antagonist | 0.191 0.013 CID_154699526 | ||
| 0.259 | 0.087 | 0.259 | Ca(v)3.3 blocker | 0.217 0.158 CID_154699526 | ||
| 0.182 | 0.012 | 0.193 | 5 Hydroxytryptamine 1F antagonist | 0.064 0.054 CID_154699877 0.193 0.011 CID_154699526 | CID_154699526 | |
| 0.196 | 0.032 | 0.373 | Toll-Like receptor antagonist | 0.373 0.004 CID_154699526 | CID_154699526 | |
| 0.196 | 0.036 | 0.209 | Catenin beta inhibitor | 0.168 0.069 CID_154699877 0.209 0.026 CID_154699526 | CID_154699526 | |
| 0.259 | 0.1 | 0.259 | Nootropic | 0.249 0.109 CID_154699877 0.186 0.178 CID_154699526 | ||
| 0.156 | 0.01 | 0.156 | 5 Hydroxytryptamine 1A agonist | 0.141 0.011 CID_154699526 | ||
| 0.147 | 0.012 | 0.176 | Lanosterol 14 alpha demethylase inhibitor | 0.176 0.006 CID_154699877 0.112 0.04 CID_154699526 | CID_154699877 | |
| 0.156 | 0.023 | 0.156 | Histamine H1 receptor antagonist | 0.15 0.024 CID_154699526 | ||
| 0.139 | 0.008 | 0.171 | Histamine H3 receptor antagonist | 0.171 0.006 CID_154699526 | CID_154699526 | |
| 0.14 | 0.017 | 0.14 | 5 Hydroxytryptamine uptake inhibitor | 0.138 0.017 CID_154699877 0.125 0.02 CID_154699526 | ||
| 0.161 | 0.043 | 0.161 | Nav1.6 sodium channel blocker | 0.131 0.079 CID_154699526 | ||
| 0.197 | 0.079 | 0.227 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.227 0.06 CID_154699526 | CID_154699526 | |
| 0.133 | 0.02 | 0.32 | NMDA 2 receptor antagonist | 0.32 0.005 CID_154699877 | CID_154699877 | |
| 0.158 | 0.046 | 0.232 | Glutamate receptor antagonist | 0.232 0.018 CID_154699877 0.153 0.049 CID_154699526 | CID_154699877 | |
| 0.135 | 0.029 | 0.355 | NMDA receptor antagonist | 0.355 0.005 CID_154699877 0.081 0.064 CID_154699526 | CID_154699877 | |
| 0.124 | 0.019 | 0.134 | Dopamine D3 antagonist | 0.134 0.018 CID_154699526 | CID_154699526 | |
| 0.115 | 0.014 | 0.115 | Sigma receptor antagonist | 0.073 0.022 CID_154699877 | ||
| 0.103 | 0.004 | 0.103 | Dopamine beta hydroxylase inhibitor | 0.054 0.023 CID_154699877 0.063 0.012 CID_154699526 | ||
| 0.147 | 0.053 | 0.288 | M18 aspartyl aminopeptidase inhibitor | 0.288 0.014 CID_154699877 0.195 0.035 CID_154699526 | CID_154699877 | |
| 0.122 | 0.029 | 0.122 | Alpha 1b adrenoreceptor antagonist | 0.113 0.031 CID_154699877 0.079 0.047 CID_154699526 | ||
| 0.1 | 0.009 | 0.234 | Histamine agonist | 0.234 0.004 CID_154699526 | CID_154699526 | |
| 0.114 | 0.023 | 0.114 | Myeloperoxidase inhibitor | 0.077 0.073 CID_154699526 | ||
| 0.191 | 0.1 | 0.211 | ErbB-1 antagonist | 0.211 0.078 CID_154699526 | CID_154699526 | |
| 0.118 | 0.028 | 0.118 | Dopamine D2 antagonist | 0.077 0.041 CID_154699526 | ||
| 0.13 | 0.043 | 0.14 | Alpha 2c adrenoreceptor antagonist | 0.14 0.037 CID_154699526 | CID_154699526 | |
| 0.217 | 0.139 | 0.264 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.264 0.094 CID_154699526 | CID_154699526 | |
| 0.098 | 0.023 | 0.172 | Toll-Like receptor 7 antagonist | 0.077 0.041 CID_154699877 0.172 0.005 CID_154699526 | CID_154699526 | |
| 0.094 | 0.019 | 0.094 | Phospholipase D inhibitor | 0.079 0.036 CID_154699877 | ||
| 0.091 | 0.018 | 0.255 | NMDA 2B receptor antagonist | 0.255 0.005 CID_154699877 0.052 0.04 CID_154699526 | CID_154699877 | |
| 0.086 | 0.014 | 0.118 | Factor IXa inhibitor | 0.118 0.006 CID_154699877 0.101 0.01 CID_154699526 | CID_154699877 | |
| 0.108 | 0.037 | 0.108 | Alpha 2d adrenoreceptor antagonist | 0.092 0.065 CID_154699877 0.105 0.041 CID_154699526 | ||
| 0.118 | 0.048 | 0.118 | Alpha adrenoreceptor antagonist | 0.113 0.05 CID_154699877 0.092 0.062 CID_154699526 | ||
| 0.077 | 0.009 | 0.115 | Dopamine D3 agonist | 0.055 0.016 CID_154699877 0.115 0.005 CID_154699526 | CID_154699526 | |
| 0.178 | 0.112 | 0.206 | 5 Hydroxytryptamine 3E antagonist | 0.206 0.053 CID_154699526 | CID_154699526 | |
| 0.101 | 0.038 | 0.135 | MAP-kinase-activated kinase inhibitor | 0.135 0.02 CID_154699526 | CID_154699526 | |
| 0.084 | 0.021 | 0.084 | 5 Hydroxytryptamine 5A antagonist | 0.067 0.035 CID_154699526 | ||
| 0.093 | 0.03 | 0.138 | Dopamine agonist | 0.063 0.05 CID_154699877 0.138 0.017 CID_154699526 | CID_154699526 | |
| 0.146 | 0.091 | 0.191 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.191 0.068 CID_154699526 | CID_154699526 | |
| 0.166 | 0.112 | 0.196 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.146 0.14 CID_154699877 0.196 0.077 CID_154699526 | CID_154699526 | |
| 0.103 | 0.049 | 0.103 | Alcohol dehydrogenase inhibitor | 0.092 0.061 CID_154699526 | ||
| 0.062 | 0.009 | 0.104 | Histamine H3 receptor agonist | 0.104 0.006 CID_154699526 | CID_154699526 | |
| 0.066 | 0.014 | 0.212 | Histamine H4 receptor antagonist | 0.212 0.003 CID_154699526 | CID_154699526 | |
| 0.088 | 0.036 | 0.12 | MAP-kinase-activated kinase 2 inhibitor | 0.12 0.019 CID_154699526 | CID_154699526 | |
| 0.097 | 0.045 | 0.097 | Alpha 1 adrenoreceptor antagonist | 0.08 0.053 CID_154699877 | ||
| 0.157 | 0.107 | 0.157 | P-glycoprotein inhibitor | |||
| 0.104 | 0.054 | 0.168 | Antiadrenergic | 0.168 0.031 CID_154699877 0.083 0.069 CID_154699526 | CID_154699877 | |
| 0.101 | 0.053 | 0.167 | Adrenaline antagonist | 0.167 0.03 CID_154699877 0.08 0.068 CID_154699526 | CID_154699877 | |
| 0.068 | 0.021 | 0.068 | 5 Hydroxytryptamine 7 agonist | 0.068 0.021 CID_154699526 | ||
| 0.07 | 0.026 | 0.07 | 5 Hydroxytryptamine 5 antagonist | 0.057 0.042 CID_154699526 | ||
| 0.103 | 0.06 | 0.129 | Folate antagonist | 0.093 0.078 CID_154699877 0.129 0.032 CID_154699526 | CID_154699526 | |
| 0.071 | 0.03 | 0.073 | Acetylcholine M5 receptor antagonist | 0.064 0.036 CID_154699877 0.073 0.028 CID_154699526 | CID_154699526 | |
| 0.084 | 0.043 | 0.084 | Alpha 1a adrenoreceptor antagonist | |||
| 0.105 | 0.07 | 0.136 | Alpha 2b adrenoreceptor antagonist | 0.136 0.046 CID_154699526 | CID_154699526 | |
| 0.07 | 0.035 | 0.074 | Alpha 1d adrenoreceptor antagonist | 0.074 0.033 CID_154699877 | CID_154699877 | |
| 0.124 | 0.089 | 0.183 | Neurotrophic factor | 0.183 0.036 CID_154699877 | CID_154699877 | |
| 0.039 | 0.004 | 0.049 | Factor IX inhibitor | 0.049 0.004 CID_154699877 0.044 0.004 CID_154699526 | CID_154699877 | |
| 0.051 | 0.017 | 0.06 | Histamine H1 receptor agonist | 0.06 0.008 CID_154699526 | CID_154699526 | |
| 0.07 | 0.039 | 0.113 | Dopamine D1 antagonist | 0.113 0.021 CID_154699526 | CID_154699526 | |
| 0.064 | 0.035 | 0.085 | Dopamine uptake inhibitor | 0.085 0.023 CID_154699877 0.056 0.042 CID_154699526 | CID_154699877 | |
| 0.062 | 0.035 | 0.062 | Sphingosine kinase inhibitor | |||
| 0.044 | 0.018 | 0.059 | Somatostatin 4 agonist | 0.038 0.025 CID_154699877 0.059 0.012 CID_154699526 | CID_154699526 | |
| 0.052 | 0.028 | 0.052 | Mineralocorticoid receptor antagonist | 0.043 0.042 CID_154699877 | ||
| 0.045 | 0.022 | 0.045 | Sphingosine kinase 1 inhibitor | |||
| 0.048 | 0.026 | 0.076 | Dopamine D5 antagonist | 0.039 0.033 CID_154699877 0.076 0.013 CID_154699526 | CID_154699526 | |
| 0.053 | 0.032 | 0.059 | Dopamine D4 agonist | 0.059 0.028 CID_154699526 | CID_154699526 | |
| 0.03 | 0.014 | 0.054 | Kainate receptor 4 antagonist | 0.024 0.018 CID_154699877 0.054 0.006 CID_154699526 | CID_154699526 | |
| 0.032 | 0.016 | 0.032 | Sigma 1 receptor antagonist | 0.026 0.019 CID_154699877 | ||
| 0.045 | 0.03 | 0.045 | Poly(ADP-ribose) polymerase inhibitor | 0.043 0.034 CID_154699526 | ||
| 0.08 | 0.066 | 0.106 | Alpha 2 adrenoreceptor antagonist | 0.106 0.043 CID_154699526 | CID_154699526 | |
| 0.159 | 0.147 | 0.159 | Tumour necrosis factor alpha release inhibitor | |||
| 0.079 | 0.068 | 0.083 | CC chemokine 5 receptor agonist | 0.083 0.055 CID_154699526 | CID_154699526 | |
| 0.07 | 0.062 | 0.094 | Nicotinic alpha4beta2 receptor antagonist | 0.094 0.037 CID_154699526 | CID_154699526 | |
| 0.093 | 0.086 | 0.116 | GABA receptor agonist | 0.116 0.06 CID_154699526 | CID_154699526 | |
| 0.048 | 0.043 | 0.048 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.035 | 0.03 | 0.035 | Poly(ADP-ribose) polymerase 1 inhibitor | |||
| 0.085 | 0.081 | 0.106 | MAP kinase kinase kinase inhibitor | 0.106 0.062 CID_154699526 | CID_154699526 | |
| 0.053 | 0.049 | 0.053 | Calcium channel T-type blocker | |||
| 0.015 | 0.015 | 0.021 | Kainate receptor 3 antagonist | 0.021 0.008 CID_154699526 | CID_154699526 | |
| 0.063 | 0.065 | 0.065 | MDM2 inhibitor | 0.065 0.053 CID_154699526 | CID_154699526 | |
| 0.05 | 0.052 | 0.054 | Prostaglandin EP2 antagonist | 0.054 0.047 CID_154699877 | CID_154699877 | |
| 0.073 | 0.077 | 0.078 | GABA A receptor agonist | 0.078 0.067 CID_154699526 | CID_154699526 | |
| 0.034 | 0.04 | 0.058 | Dopamine D2 agonist | 0.058 0.022 CID_154699526 | CID_154699526 | |
| 0.059 | 0.066 | 0.111 | Polo-like kinase-2 inhibitor | 0.111 0.017 CID_154699526 | CID_154699526 | |
| 0.055 | 0.064 | 0.095 | 5 Hydroxytryptamine 3A antagonist | 0.095 0.019 CID_154699526 | CID_154699526 | |
| 0.014 | 0.023 | 0.03 | Kainate receptor 5 antagonist | 0.03 0.009 CID_154699526 | CID_154699526 | |
| 0.066 | 0.075 | 0.14 | Platelet growth factor antagonist | 0.14 0.022 CID_154699526 | CID_154699526 | |
| 0.026 | 0.035 | 0.068 | Kainate receptor 2 antagonist | 0.068 0.009 CID_154699526 | CID_154699526 | |
| 0.189 | 0.202 | 0.229 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.229 0.098 CID_154699526 | CID_154699526 | |
| 0.032 | 0.045 | 0.044 | Nicotinic acid receptor 1 agonist | 0.044 0.024 CID_154699526 | CID_154699526 | |
| 0.133 | 0.153 | 0.142 | Death-associated protein kinase 2 inhibitor | 0.142 0.127 CID_154699526 | CID_154699526 | |
| 0.043 | 0.068 | 0.058 | Adenosine A2a receptor antagonist | 0.058 0.047 CID_154699526 | CID_154699526 | |
| 0.055 | 0.087 | 0.085 | Alpha 2a adrenoreceptor antagonist | 0.085 0.045 CID_154699526 | CID_154699526 | |
| 0.066 | 0.098 | 0.078 | Histamine H2 receptor antagonist | 0.078 0.069 CID_154699526 | CID_154699526 | |
| 0.039 | 0.072 | 0.054 | 5 Hydroxytryptamine 6 antagonist | 0.054 0.043 CID_154699526 | CID_154699526 | |
| 0.052 | 0.085 | 0.086 | Acetylcholine M4 receptor antagonist | 0.086 0.041 CID_154699526 | CID_154699526 | |
| 0.022 | 0.062 | 0.052 | Potassium channel (Inward rectifier) 1 blocker | 0.052 0.004 CID_154699877 | CID_154699877 | |
| 0.137 | 0.178 | 0.224 | Interleukin agonist | 0.224 0.099 CID_154699877 0.161 0.157 CID_154699526 | CID_154699877 | |
| 0.032 | 0.077 | 0.068 | Adenosine A1 receptor antagonist | 0.068 0.034 CID_154699526 | CID_154699526 | |
| 0.036 | 0.082 | 0.058 | Alpha 1 adrenoreceptor agonist | 0.058 0.039 CID_154699877 | CID_154699877 | |
| 0.084 | 0.134 | 0.107 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.107 0.095 CID_154699526 | CID_154699526 | |
| 0.096 | 0.148 | 0.166 | Acetylcholine M1 receptor antagonist | 0.137 0.087 CID_154699877 0.166 0.061 CID_154699526 | CID_154699526 | |
| 0.179 | 0.235 | 0.341 | Antiobesity | 0.341 0.092 CID_154699877 | CID_154699877 | |
| 0.037 | 0.093 | 0.054 | Carbonic anhydrase stimulant | 0.054 0.048 CID_154699877 | CID_154699877 | |
| 0.007 | 0.063 | 0.025 | AMPA 1 receptor antagonist | 0.025 0.023 CID_154699526 | CID_154699526 | |
| 0.05 | 0.106 | 0.072 | Calcium antagonist | 0.072 0.071 CID_154699877 | CID_154699877 | |
| 0.03 | 0.089 | 0.103 | Toll-Like receptor 8 antagonist | 0.103 0.008 CID_154699526 | CID_154699526 | |
| 0.008 | 0.068 | 0.047 | Histamine H4 receptor agonist | 0.047 0.005 CID_154699526 | CID_154699526 | |
| 0.141 | 0.202 | 0.232 | MAP-kinase-activated kinase 5 inhibitor | 0.232 0.072 CID_154699526 | CID_154699526 | |
| 0.16 | 0.224 | 0.261 | Angiogenesis inhibitor | 0.261 0.115 CID_154699526 | CID_154699526 | |
| 0.05 | 0.115 | 0.098 | Acetylcholine nicotinic agonist | 0.098 0.039 CID_154699526 | CID_154699526 | |
| 0.021 | 0.093 | 0.066 | AMPA receptor antagonist | 0.066 0.022 CID_154699526 | CID_154699526 | |
| 0.023 | 0.099 | 0.042 | AMPA 4 receptor antagonist | 0.042 0.023 CID_154699526 | CID_154699526 | |
| 0.029 | 0.106 | 0.05 | Nicotinic alpha7 receptor agonist | 0.05 0.043 CID_154699526 | CID_154699526 | |
| 0.064 | 0.142 | 0.142 | 5 Hydroxytryptamine 3A agonist | 0.142 0.04 CID_154699526 | CID_154699526 | |
| 0.039 | 0.119 | 0.076 | Benzodiazepine agonist | 0.076 0.043 CID_154699526 | CID_154699526 | |
| 0.036 | 0.119 | 0.063 | Fibroblast growth factor 2 antagonist | 0.063 0.048 CID_154699526 | CID_154699526 | |
| 0.132 | 0.217 | 0.253 | 5 Hydroxytryptamine 1E antagonist | 0.253 0.071 CID_154699526 | CID_154699526 | |
| 0.032 | 0.121 | 0.061 | Cyclin D1 inhibitor | 0.061 0.042 CID_154699526 | CID_154699526 | |
| 0.046 | 0.137 | 0.106 | Fibroblast growth factor 1 antagonist | 0.106 0.053 CID_154699526 | CID_154699526 | |
| 0.013 | 0.104 | 0.041 | Kainate receptor antagonist | 0.041 0.028 CID_154699526 | CID_154699526 | |
| 0.025 | 0.118 | 0.051 | Nicotinic neuronal receptor agonist | 0.051 0.044 CID_154699526 | CID_154699526 | |
| 0.058 | 0.151 | 0.116 | Ferrochelatase inhibitor | 0.092 0.08 CID_154699877 0.116 0.056 CID_154699526 | CID_154699526 | |
| 0.047 | 0.146 | 0.134 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.134 0.06 CID_154699526 | CID_154699526 | |
| 0.067 | 0.172 | 0.088 | Phosphodiesterase 6D inhibitor | 0.088 0.081 CID_154699526 | CID_154699526 | |
| 0.135 | 0.247 | 0.304 | Gastrin inhibitor | 0.304 0.03 CID_154699526 | CID_154699526 | |
| 0.084 | 0.201 | 0.121 | MAP3K9 inhibitor | 0.121 0.113 CID_154699877 0.12 0.114 CID_154699526 | CID_154699877 | |
| 0.028 | 0.146 | 0.084 | Neuronal nicotinic receptor antagonist | 0.084 0.033 CID_154699526 | CID_154699526 | |
| 0.031 | 0.152 | 0.047 | Phosphodiesterase 6C inhibitor | 0.047 0.03 CID_154699526 | CID_154699526 | |
| 0.039 | 0.16 | 0.079 | ALK inhibitor | 0.079 0.061 CID_154699526 | CID_154699526 | |
| 0.01 | 0.134 | 0.046 | 5 Hydroxytryptamine 3B antagonist | 0.046 0.017 CID_154699526 | CID_154699526 | |
| 0.219 | 0.343 | 0.268 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.268 0.259 CID_154699526 | CID_154699526 | |
| 0.059 | 0.186 | 0.126 | Ribosomal protein S6 kinase inhibitor | 0.126 0.084 CID_154699526 | CID_154699526 | |
| 0.064 | 0.193 | 0.307 | Toll-Like receptor 9 antagonist | 0.307 0.012 CID_154699526 | CID_154699526 | |
| 0.028 | 0.158 | 0.081 | Phosphodiesterase 5A inhibitor | 0.081 0.039 CID_154699526 | CID_154699526 | |
| 0.023 | 0.153 | 0.08 | 5 Hydroxytryptamine 3 antagonist | 0.08 0.024 CID_154699526 | CID_154699526 | |
| 0.02 | 0.151 | 0.051 | 5 Hydroxytryptamine 4 antagonist | 0.051 0.036 CID_154699526 | CID_154699526 | |
| 0.028 | 0.159 | 0.081 | Phosphodiesterase V inhibitor | 0.081 0.04 CID_154699526 | CID_154699526 | |
| 0.035 | 0.17 | 0.1 | Phosphodiesterase 1A inhibitor | 0.1 0.01 CID_154699526 | CID_154699526 | |
| 0.039 | 0.174 | 0.118 | Histamine N-methyltransferase inhibitor | 0.118 0.031 CID_154699526 | CID_154699526 | |
| 0.037 | 0.189 | 0.092 | Adrenaline agonist | 0.092 0.044 CID_154699877 | CID_154699877 | |
| 0.035 | 0.191 | 0.061 | Beta 3 adrenoreceptor antagonist | 0.061 0.052 CID_154699877 | CID_154699877 | |
| 0.017 | 0.183 | 0.032 | Protein kinase C beta I inhibitor | 0.032 0.027 CID_154699526 | CID_154699526 | |
| 0.049 | 0.215 | 0.102 | Polo-like kinase-1 inhibitor | 0.102 0.043 CID_154699526 | CID_154699526 | |
| 0.027 | 0.203 | 0.083 | Acetylcholine nicotinic antagonist | 0.083 0.052 CID_154699526 | CID_154699526 | |
| 0.021 | 0.204 | 0.075 | Fibroblast growth factor 3 antagonist | 0.075 0.057 CID_154699526 | CID_154699526 | |
| 0.042 | 0.227 | 0.063 | Prolactin release inhibitor | 0.063 0.042 CID_154699526 | CID_154699526 | |
| 0.028 | 0.217 | 0.082 | Phosphodiesterase 1B inhibitor | 0.082 0.022 CID_154699526 | CID_154699526 | |
| 0.02 | 0.229 | 0.093 | Protein kinase C beta inhibitor | 0.093 0.017 CID_154699526 | CID_154699526 | |
| 0.035 | 0.245 | 0.097 | DNA intercalator | 0.097 0.076 CID_154699526 | CID_154699526 | |
| 0.016 | 0.227 | 0.054 | Nicotinic receptor alpha7 subunit antagonist | 0.054 0.037 CID_154699526 | CID_154699526 | |
| 0.084 | 0.309 | 0.186 | Cardiotonic | 0.186 0.133 CID_154699877 | CID_154699877 | |
| 0.127 | 0.358 | 0.22 | Calcium channel activator | 0.22 0.185 CID_154699877 | CID_154699877 | |
| 0.122 | 0.356 | 0.211 | Tyrosine 3 hydroxylase inhibitor | 0.211 0.116 CID_154699526 | CID_154699526 | |
| 0.032 | 0.269 | 0.072 | Phosphodiesterase 1C inhibitor | 0.072 0.027 CID_154699526 | CID_154699526 | |
| 0.023 | 0.267 | 0.058 | 5 Hydroxytryptamine 3 agonist | 0.058 0.052 CID_154699526 | CID_154699526 | |
| 0.037 | 0.285 | 0.114 | Phosphodiesterase I inhibitor | 0.114 0.031 CID_154699526 | CID_154699526 | |
| 0.041 | 0.294 | 0.17 | Psychostimulant | 0.17 0.1 CID_154699526 | CID_154699526 | |
| 0.076 | 0.332 | 0.157 | Focal adhesion kinase 2 inhibitor | 0.157 0.12 CID_154699526 | CID_154699526 | |
| 0.113 | 0.378 | 0.394 | GABA C receptor rho-3 antagonist | 0.394 0.064 CID_154699526 | CID_154699526 | |
| 0.06 | 0.332 | 0.186 | DNA methylase inhibitor | 0.186 0.088 CID_154699526 | CID_154699526 | |
| 0.043 | 0.315 | 0.127 | Activin receptor-like kinase 2 inhibitor | 0.127 0.089 CID_154699526 | CID_154699526 | |
| 0.129 | 0.403 | 0.283 | Cyclophilin D inhibitor | 0.283 0.178 CID_154699877 | CID_154699877 | |
| 0.098 | 0.378 | 0.138 | Ca2+-transporting ATPase inhibitor | 0.138 0.082 CID_154699526 | CID_154699526 | |
| 0.031 | 0.316 | 0.144 | Protein kinase C gamma inhibitor | 0.144 0.035 CID_154699526 | CID_154699526 | |
| 0.015 | 0.301 | 0.053 | Protein kinase C eta inhibitor | 0.053 0.04 CID_154699526 | CID_154699526 | |
| 0.092 | 0.383 | 0.365 | Vasodilator, peripheral | 0.365 0.068 CID_154699877 0.284 0.105 CID_154699526 | CID_154699877 | |
| 0.138 | 0.433 | 0.412 | Calcium channel L-type activator | 0.412 0.073 CID_154699877 | CID_154699877 | |
| 0.025 | 0.327 | 0.101 | Polo-like kinase-4 inhibitor | 0.101 0.076 CID_154699526 | CID_154699526 | |
| 0.024 | 0.327 | 0.126 | Falcipain 3 inhibitor | 0.126 0.049 CID_154699526 | CID_154699526 | |
| 0.055 | 0.376 | 0.151 | GABA C receptor rho-2 antagonist | 0.151 0.072 CID_154699526 | CID_154699526 | |
| 0.031 | 0.367 | 0.165 | Cytidine deaminase inhibitor | 0.165 0.065 CID_154699526 | CID_154699526 | |
| 0.025 | 0.372 | 0.085 | Prolactin inhibitor | 0.085 0.073 CID_154699526 | CID_154699526 | |
| 0.058 | 0.415 | 0.278 | Cyclic AMP phosphodiesterase inhibitor | 0.278 0.051 CID_154699526 | CID_154699526 | |
| 0.031 | 0.504 | 0.143 | DNA methyltransferase I inhibitor | 0.143 0.112 CID_154699526 | CID_154699526 | |
| 0.012 | 0.55 | 0.11 | Bronchodilator | 0.11 0.052 CID_154699877 | CID_154699877 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |